Our People

Tom Theriault, PhD Chief Scientific Officer

Tom has years of cancer vaccine and antibody development experience from his time at Genitope, and is excited to apply the lessons from Genitope in developing Bullet Bio’s products. As Vice President of Research & Development at Genitope, Tom and his team were responsible for a wide range of research and development activities including pipeline therapeutic development, animal model studies, mechanism of action studies, clinical assay development and operations for immune response and minimum residual disease, as well as assay and process development for clinical manufacturing.

After a post-doctoral program at the California Institute of Technology, Tom started his career in industry by co-founding Combion, a DNA microarray company that was acquired by Incyte Genomics. He continued to work for Incyte for 8 years at various levels in Research, Target Validation and Technology Development, ending as VP of Research before entering the world of cancer immunotherapy. 

Tom obtained his PhD from Stanford University and his bachelor’s in Chemistry from Dartmouth College. Tom enjoys sailing and skiing.

 


Back to All